Publication | Closed Access

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Gemcitabine–docetaxel Versus Cisplatin–vinorelbineMedicineAnti-cancer AgentPhase Iii StudyCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyRadiologyHealth Sciences